Sphinx Pharmaceuticals — 8 Patents, Ranked #69,175

Patents per Year

Showing 1–7 of 7 inventors

Patent	Est. Value	Year
Bis-(hydroxylakylamino)-anthraquinone inhibitors of protein kinase C	$2M	1994
1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase C	$1M	1992
N,N'-bis(sulfonamido)-2-amino-4-iminonaphthalen-1-ones and N,N'-bis(amido)-2-amino-4-iminonaphthalen-1-ones	$1M	1994
Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C	$1M	1993
Furo-coumarinsulfonamides as protein kinase C inhibitors	$957K	1993